The University of Arizona College of Medicine – Phoenix and Onvida Health are partnering to launch Arizona’s first rural regional medical school branch. Deeply rooted in community, the partnership will address the severe physician shortage facing the rural regions of the state.Continue reading
Author Archive: AZBio
Smarter tools for peering into the microscopic world
Breakthroughs in microbial analysis could enhance disease prediction, environmental protection and our understanding of the planet’s smallest life formsContinue reading
AZBio Celebrates Trailblazers 2025
AZBio and members of the Arizona Business and Bioscience Community came together honor Arizona Legislators and State and Local Elected Officials who have made it possible for the Arizona Bioscience Industry to gain national recognition, build capital infrastructure, and take its place as a leader in both scientific discovery and job growth.Continue reading
Biennial Report on Best Practices in Bioscience Economic Development Initiatives Released
WASHINGTON, DC (December 2, 2025) – The Biotechnology Innovation Organization (BIO), in partnership with the Council of State Bioscience Associations (CSBA), released today its latest biennial report on best practices in bioscience economic development initiatives: The U.S. Bioscience Industry: A Powerful Engine for State Economies.Continue reading
Governor Katie Hobbs Appoints Debbie Johnston to Lead Arizona Department of Health Services
News Release November 24, 2025 – Phoenix, AZ – Today, Governor Katie Hobbs announced the appointment of Debbie Johnston to lead the Arizona Department of Health Services. For the past 21 years, she has worked for the Arizona Hospital and Healthcare Association (AzHHA), focusing on policy development and regulatory affairs. During her tenure at AzHHA, Debbie served on various public health boards and committees at the Arizona Department of Health Services, including the State Trauma Advisory Board and the Arizona Health Improvement Plan Steering Committee. Debbie retired earlier this year as Executive Vice President for the Association.Continue reading
Abbott to acquire Exact Sciences, a leader in large and fast-growing cancer screening and precision oncology diagnostics segments
- Acquisition adds a new growth vertical to Abbott’s already high single-digit growth profile, gaining leadership in the fast-growing $60 billion U.S. cancer screening and precision oncology diagnostics segments
- Acquisition will uniquely position Abbott to transform cancer care, advancing earlier detection and optimizing treatment and monitoring to help millions more people live healthier lives
- Exact Sciences’ product lines feature advanced cancer screening and diagnostic solutions, including the market-leading Cologuard® and Oncotype DX® tests, and cutting-edge liquid biopsy tests for multi-cancer early detection and molecular residual disease testing
- Acquisition will be immediately accretive to Abbott’s revenue growth and gross margin
- Abbott to host investor call today at 8 a.m. Central Time/9 a.m. Eastern Time
Hexoskin Medical System Receives FDA 510(k) Clearance for Long-Term ECG and Respiratory Monitoring
Montreal, Canada — November 19, 2025 — Carré Technologies Inc. (dba Hexoskin), a pioneer in wearable health technologies, today announced that its Hexoskin Medical System (HMS) has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for continuous long-term ECG, respiratory monitoring, and activity. The system, which includes a smart biometric shirt and a secure data management platform, has now been cleared for use in the United States to record, display, and store electrocardiogram (ECG) and respiratory signals in ambulatory patients.
The Hexoskin Medical System enables real-world cardiopulmonary monitoring—a critical unmet need in healthcare and clinical research. With FDA clearance, HMS becomes one of the first medical-grade wearable systems capable of long-term ECG and respiratory measurements outside the clinic, transforming how patients are monitored and how treatments are evaluated.Continue reading
CMS launches payment model to lower Medicaid drug spending
The Center for Medicare and Medicaid Innovation (CMMI) will begin a voluntary, 5-year payment model in January called Generating Cost Reductions for U.S. Medicaid, or GENEROUS, under which state Medicaid programs will be able to buy drugs included in the pilot program at prices that align with what other countries pay.Continue reading
Barby Ingle Appointed Biopharma Rep to Arizona Rare Disease Advisory Council
PHOENIX, Ariz. – October 29, 2025 – Barby Ingle is a chronic pain educator, best-selling author, and patient advocate. Arizona Senate President Warren Petersen has appointed Mrs. Ingle to the newly formed Arizona Rare Disease Advocacy Council. Her role is Biopharma Representative on the Arizona Rare Disease Advisory Council (RDAC). This recognizes her expertise in rare disease advocacy and industry. It also honors her dedication to improving access to care for underserved patients.
ASU researcher on the importance of considering sex differences in health studies
It has long been understood that there are biological differences between sexes, but it has only been around a decade since federally funded biomedical research has been required to include females in the U.S.
And it is more important than ever to recognize the importance of these differences and to fully fund research on women’s health, according to Arizona State University President’s Professor Heather Bimonte-Nelson, who has been studying female neurobiology and the impact of hormones during aging for decades.Continue reading